The next board meeting for Madrigal Pharmaceuticals Inc is on 08 Sep 2025 for the purpose of Morgan Stanley 23(rd) Annual Global Health Care ConferenceSee details
Madrigal Pharmaceuticals Inc has a share price target of US$ 469, revenue growth forecast of 386.2%, and profit growth estimate of 56.7% for FY25, based on top 15 analyst calls.